258 HORIZON-01: a Phase I–III Platform Study Evaluating the Efficacy and Safety of Multiple Therapies in Patients with Biomarker-Defined Locally Advanced, Unresectable Stage III Non-Small Cell Lung Cancer (NSCLC)
Lung Cancer（2025）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined